
Sign up to save your podcasts
Or


Send us a text
Nick Jikomes talks to Jeff Ubersax, PhD, CEO of the biotechnology company Demetrix (who supported this episode). Jeff discussed the science behind how Demetrix is engineering baker's yeast to produce cannabinoids at an industrial scale, with a focus on making rare cannabinoids other than THC and CBD.
Jeff also discussed how he transitioned from academic science to running his own company, and offered advice for academic scientists in training who might be thinking about moving into biotechnology.
Episode Support: This episode was supported by Demetrix, a biotechnology company using cutting edge fermentation technology to produce rare cannabinoids that are safe, legal, and effective for health and wellness.
Support the show
Affiliates:
For all the ways you can support my efforts
By Nick Jikomes4.8
7878 ratings
Send us a text
Nick Jikomes talks to Jeff Ubersax, PhD, CEO of the biotechnology company Demetrix (who supported this episode). Jeff discussed the science behind how Demetrix is engineering baker's yeast to produce cannabinoids at an industrial scale, with a focus on making rare cannabinoids other than THC and CBD.
Jeff also discussed how he transitioned from academic science to running his own company, and offered advice for academic scientists in training who might be thinking about moving into biotechnology.
Episode Support: This episode was supported by Demetrix, a biotechnology company using cutting edge fermentation technology to produce rare cannabinoids that are safe, legal, and effective for health and wellness.
Support the show
Affiliates:
For all the ways you can support my efforts

557 Listeners

7,213 Listeners

5,019 Listeners

1,546 Listeners

2,337 Listeners

310 Listeners

702 Listeners

366 Listeners

50 Listeners

245 Listeners

111 Listeners

61 Listeners

119 Listeners

69 Listeners

3,093 Listeners